CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,718,100 | +66.0% | 305,000 | 0.0% | 8.87% | +126.3% |
| Q1 2023 | $7,060,750 | -30.0% | 305,000 | -20.8% | 3.92% | -23.5% |
| Q4 2022 | $10,087,000 | -2.3% | 385,000 | -26.7% | 5.13% | +35.5% |
| Q3 2022 | $10,322,000 | -4.0% | 525,000 | -14.6% | 3.78% | -12.1% |
| Q2 2022 | $10,756,000 | +20.6% | 615,000 | +12.8% | 4.30% | +44.2% |
| Q1 2022 | $8,916,000 | +0.3% | 545,000 | 0.0% | 2.98% | +21.7% |
| Q4 2021 | $8,889,000 | +49.8% | 545,000 | +17.2% | 2.45% | +57.5% |
| Q3 2021 | $5,933,000 | +0.9% | 465,000 | +11.6% | 1.56% | +14.1% |
| Q2 2021 | $5,882,000 | +83.9% | 416,567 | +102.4% | 1.36% | +53.6% |
| Q1 2021 | $3,198,000 | -2.0% | 205,799 | 0.0% | 0.89% | -27.2% |
| Q4 2020 | $3,264,000 | – | 205,799 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |